Cart
sales@molnova.com
3,4-Dimethoxychalcone
CAS No. 5416-71-7
3,4-Dimethoxychalcone( —— )
Catalog No. M37752 CAS No. 5416-71-7
3,4-Dimethoxychalcone is a natural product found in the flowers of Arrabidaea brachypoda.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 32 | In Stock |
|
| 500MG | 49 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3,4-Dimethoxychalcone
-
NoteResearch use only, not for human use.
-
Brief Description3,4-Dimethoxychalcone is a natural product found in the flowers of Arrabidaea brachypoda.
-
Description3,4-Dimethoxychalcone is a Caloric restriction mimetics (CRMs). 3,4-Dimethoxychalcone induces the deacetylation of cytoplasmic proteins and stimulates autophagy flux. 3,4-Dimethoxychalcone can be used for cardiac and cancer diseases research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5416-71-7
-
Formula Weight268.31
-
Molecular FormulaC17H16O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (372.70 mM; Ultrasonic )
-
SMILESCOC1=CC=C(\C=C\C(=O)C2=CC=CC=C2)C=C1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Okolo EN, et al. New chalcone derivatives as potential antimicrobial and antioxidant agent. Sci Rep. 2021 Nov 5;11(1):21781.?
molnova catalog
related products
-
Lilial
Lilial (a trade name for lily aldehyde, also known as lysmeral) is a chemical compound commonly used as a perfume in cosmetic preparations and laundry powders, often under the name butylphenyl methylpropional.?
-
6-Hydroxykynurenic a...
6-Hydroxykynurenic acid (6-HKA) is a derivative of kynurenic acid (KYNA) and can be isolated from Ginkgo leaves. 6-Hydroxykynurenic acid is a low-affinity NMDAR antagonist (IC50: 59 μM).
-
Theralizumab
Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells.
